≥99% HPLCBatch testedIdentity by MS, purity by HPLC
Lot numberedCertificate filed per lot
Cold stored2 to 8 °C until dispatch
AOD9604
2mg lyophilised powderCAS 221231-10-3
A fragment modelled on the tail of human growth hormone, studied for lipid-metabolism pathways without the full hormone's activity.
£19.90per vial, VAT included
In stock, dispatched same day before 16:00
- Free shipping on UK orders over £20.00
- Same day dispatch on orders placed before 16:00
- Batch certificate in the COA Database
Sold for research purposes only. For in-vitro laboratory research. Not a medicine and not for human or animal consumption. Supplied to qualified individuals aged 18 and over; you confirm this at checkout.
Research overview
AOD9604 is a 16-residue peptide modelled on the tail of human growth hormone, a modified 176-191 fragment with a Cys7-Cys14 disulfide bond. It is studied for lipid-metabolism pathways without the full hormone's activity. Supplied at 2mg as a lyophilised powder for in-vitro laboratory research only.
The C-terminal region of growth hormone has been examined as a fragment that keeps some of the lipid-metabolising activity reported for the hormone while lacking its growth-promoting and glucose-raising effects. In adipocyte culture and preclinical models, AOD9604 has been reported to influence lipolysis and lipogenesis. The signalling route is not fully resolved, and published work suggests it may not depend on the classical growth hormone receptor.
Researchers use it in adipocyte assays that measure glycerol and free fatty acid release, in gene-expression studies of lipid-handling enzymes, and in receptor-binding comparisons with intact growth hormone. It is often studied alongside HGH Frag 176-191 to compare closely related fragments. Disulfide integrity is usually confirmed by mass spectrometry. It is supplied as a lyophilised powder.
Research areas
- Lipolysis and lipogenesis in adipocyte cultures
- Free fatty acid and glycerol release assays
- Receptor-independent signalling hypotheses
- Disulfide-bonded peptide characterisation
- Comparison with HGH Frag 176-191
Specifications
- CAS number
- 221231-10-3
- Molecular formula
- C78H123N23O23S2
- Molecular weight
- ~1,815.1 g/mol.
- Sequence
- Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe (YLRIVQCRSVEGSCGF; Cys7-Cys14 disulfide; hGH 176-191 analogue)
- Form
- lyophilised powder
- Purity
- ≥99% (HPLC)
- Also known as
- AOD9604, Synthetic hGH Fragment (176-191), Modified C-terminal Growth Hormone Peptide.
- Supplied as
- 2mg per vial, lyophilised powder
Storage and handling
Store the lyophilised powder in a freezer, protected from moisture and light, and let the vial reach room temperature before opening. Reconstitute with an appropriate laboratory diluent and keep reconstituted material cold.
Certificates of analysis
Each lot of AOD9604 is released with a certificate recording identity and purity. Enter the lot number printed on your vial on the lab testing page to view it.
Questions
How does AOD9604 differ from HGH Frag 176-191?
Both are based on the C-terminal 176-191 region of human growth hormone. AOD9604 is described as a modified analogue of that fragment with a Cys7-Cys14 disulfide bond, and the two are often compared side by side.
How is AOD9604 supplied and stored?
It is a lyophilised powder in a 2mg vial. Keep it cold, dry and away from light, and reconstitute with a suitable laboratory diluent only when the material is needed.
Is AOD9604 a medicine?
No. It is supplied strictly for in-vitro laboratory research. It is not a medicine, food or supplement, and it is not for human or animal use. Buyers must be aged 18 or over.
Metabolic
Studied alongside
